1. We hypothesize that exercise training in breast cancer survivors positively affects patients quality of life, on the short- and longterm. 2. We hypothesize that the cohort multiple Randomised Controlled Trial (cmRCT) is a more suitable design…
ID
Bron
Verkorte titel
Aandoening
Breast cancer
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
- Quality of life<br>
- Fatigue<br>
- Anxiety and depression<br>
- Physical activity level and sedentary time
Achtergrond van het onderzoek
Rationale: The evidence for beneficial effects of exercise training in breast cancer survivors is growing, however, the long-term effects of structured exercise programmes are not clear yet. Furthermore, former trials have been performed in a highly controlled lab setting and included patients comprising a selected group of relatively young, and high educated women who were physically active before diagnosis. Inclusion of this selected group might have led to contamination (i.e. control participants adopt the exercise intervention) in these trials which might have diluted results and explain part of the small effect sizes found. Moreover, it hampers generalization of results. Exercise-oncology trials also suffer from difficult accrual since eligible patients do not want to be randomized to the control group. To overcome these problems, the cohort multiple Randomised Controlled Trial (cmRCT) is hypothesized be a more suitable design for this field. In a cmRCT, the intervention study is performed embedded in an on-going prospective cohort study with regular follow-up measurements. This design also provides an excellent opportunity to gain long-term results.
Objective: Aim of this study is to assess the effects of exercise intervention on breast cancer patients’ quality of life on the short (6 months) and long-term (24 months) according to the cmRCT design. In addition, we will evaluate the concept of the cmRCT design in the field of exercise oncology.
Study design: Randomized controlled trial, nested within a prospective cohort (UMBRELLA) according to the ‘cohort multiple randomized controlled trial’ (cmRCT) design. UMBRELLA is a prospective cohort study including all breast cancer patients visiting the UMC Utrecht department of Radiotherapy .
Study population: Breast cancer patients participating in the UMBRELLA cohort who meet the following criteria: 1) UMBRELLA informed consent for randomization to future research/ intervention studies; 2) 18-75 years of age; 3) 12 months to18 months post diagnosis, 4) primary cancer treatment completed (except for hormonal treatment), and 5) a physically inactive lifestyle.
Intervention: A 12-week structured exercise programme, consisting of two one-hour supervised fitness (group) sessions at a physiotherapist centre per week. The training programme is a combination of high intensity endurance training and strength training.
Main study parameters/endpoints: The primary endpoints for this study are: quality of life (primary patient-related outcome), fatigue, and physical activity levels on the long-term. Secondary outcomes are methodological: i.e. contamination, participation, retention and the composition of the study population.
Doel van het onderzoek
1. We hypothesize that exercise training in breast cancer survivors positively affects patients quality of life, on the short- and longterm.
2. We hypothesize that the cohort multiple Randomised Controlled Trial (cmRCT) is a more suitable design for exercise-oncology trials.
Onderzoeksopzet
- Baseline (start exercise programme)
- 12 weeks (end exercise programme)
- Questionnaires at regular intervals within the UMBRELLA cohort (after diagnosis, 6, 12, 18, 24, 36, 48, etc. months)
Onderzoeksproduct en/of interventie
- Intervention group: 12-week structured exercise programme with two combined strength- and endurance trainingssessions a week under supervision of a physiotherapist. In addition, patients will be asked to increase physical activity outside the program and reduce sedentary behaviour.
- Control group: care as usual
Algemeen / deelnemers
Roxanne Gal
Huispostnummer Str. 6.131 - Postbus 85500
Utrecht 3508 GA
The Netherlands
T +31 (0)88 75 696 24
r.gal@umcutrecht.nl
Wetenschappers
Roxanne Gal
Huispostnummer Str. 6.131 - Postbus 85500
Utrecht 3508 GA
The Netherlands
T +31 (0)88 75 696 24
r.gal@umcutrecht.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
- Adult women with breast cancer visiting the radiotherapy department of the University Medical Center Utrecht
- Mentally able to understand and sign informed consent
- Able to speak, read and understand Dutch
- UMBRELLA informed consent for randomization to future research/ intervention studies
- 18-75 years of age
- 12 months to18 months post diagnosis
- Primary cancer treatment completed (except for hormonal treatment)
- Physically inactive lifestyle (<150 min per week moderate to intensive activities (>= MET4))
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Contra-indications for excercise
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL5381 |
NTR-old | NTR5482 |
CCMO | NL52062.041.15 |
OMON | NL-OMON47246 |